ATR 1072 — IND submission
H2 2026
Submit IND application for ATR 1072 in the second half of 2026Source filing
RNA biotech catalysts & pipeline
ATRIUM THERAPEUTICS INC · Data as of 2026-10-27
Upcoming catalysts
ATR 1086 — IND submission
in 2027
File IND application for ATR 1086 in 2027, with IND-enabling studies initiating in 2026.Source filing
ATR 1072 — Initial data
H2 2027
The Company expects to report initial proof-of-concept data from Corventis in the second half of 2027.Source filing